🇺🇸 FDA
Patent

US 8323906

Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

granted A61PA61P35/00

Quick answer

US patent 8323906 (Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer) held by The Board of Regents of the University of Texas System expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P35/00